Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Beginning Cash Position : HK$1,299.1 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Beginning Cash Position?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Beginning Cash Position for the quarter that ended in Mar. 2024 was HK$1,299.1 Mil.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's quarterly Beginning Cash Position declined from Sep. 2023 (HK$1,439.1 Mil) to Dec. 2023 (HK$1,434.8 Mil) and declined from Dec. 2023 (HK$1,434.8 Mil) to Mar. 2024 (HK$1,299.1 Mil).

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's annual Beginning Cash Position declined from Dec. 2021 (HK$1,710.4 Mil) to Dec. 2022 (HK$1,350.0 Mil) but then increased from Dec. 2022 (HK$1,350.0 Mil) to Dec. 2023 (HK$1,410.2 Mil).

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Beginning Cash Position Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Beginning Cash Position Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

654.55

683.76

1,710.45

1,349.98

1,410.21

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															1,468.51	1,027.62	1,439.14	1,434.78	1,299.10

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

688505:China

Address

No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210

Website

http://www.fd-zj.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Headlines

No Headlines